Skip to main content
Log in

Thiopurine S-methyltransferase as a target for drug interactions

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The present study was undertaken to investigate the possible effects of various agents on thiopurine methyltransferase (TPMT) activity in red blood cells (RBCs) from patients with chronic inflammatory bowel disease (IBD).

Methods

In three groups of patients with very high, normal and intermediate TPMT activity (each n=6), the inhibitory potential of furosemide, piretanide, azathioprine (AZA) and testosterone was assessed by ex vivo measurements of TPMT activity in RBCs. From individual concentration–response curves, IC50 values have been determined.

Results

Independent of the basal TPMT activity, lowest IC50 values were calculated for furosemide (15–19 μM), followed by testosterone (30–72 μM), piretanide (300–313 μM) and AZA (430–532 μM). Compared with reported plasma concentration achieved during treatment, only furosemide would have the potential to inhibit TPMT also in vivo, whereas the IC50 values of the other agents are far above the corresponding plasma levels.

Conclusions

Our ex vivo study revealed that only furosemide has the potential to inhibit TPMT activity in patients with IBD. This possibility should be taken into consideration if the diuretic and AZA or 6-mercaptopurine are coadministered. However, the extrapolation to the clinical setting remains open.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429

    Article  CAS  PubMed  Google Scholar 

  2. Lennard L (2002) TPMT in the treatment of Crohn’s disease with azathioprine. Gut 51:143–146

    Article  CAS  PubMed  Google Scholar 

  3. Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger U, Schwab M (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407–417

    Article  CAS  PubMed  Google Scholar 

  4. Egan LJ (2004) Drug interactions in gastroenterology: mechanisms, consequences, and how to avoid. Clin Gastroenterol Heptol 2:725–730

    Article  Google Scholar 

  5. Szumlanski CL, Weinshilboum RM (1995) Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 39:456–459

    CAS  PubMed  Google Scholar 

  6. Xin HW, Fischer C, Schwab M, Klotz U (2005) Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease. Aliment Pharmacol Ther 21:1105–1109

    Article  CAS  PubMed  Google Scholar 

  7. Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44:147–152

    Google Scholar 

  8. Lysaa RA, Giverhaug T, Wold HL, Aarbakke J (1996) Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide. Eur J Clin Pharmacol 49:393–396

    Article  CAS  PubMed  Google Scholar 

  9. Capdeville R, Mousson B, Bax G, Bertrand Y, Philippe N (1994) Interactions between 6-mercaptopurine therapy and thiopurine methyltransferase (TPMT) activity. Eur J Clin Pharmacol 46:385–386

    Article  CAS  PubMed  Google Scholar 

  10. Lennard L, Lilleyman JS, van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336:225–229

    Article  CAS  PubMed  Google Scholar 

  11. McLeod HL, Relling MV, Liu Qing, Pui CH, Evans WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukaemia. Blood 85:1897–1902

    CAS  PubMed  Google Scholar 

  12. Arenas M, Duley JA, Ansari A, Schobowale-Bakre EA, Fairbanks L, Soon SY, Sanderson J, Marinaki AM (2004) Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype. Nucleosides Nucleotides Nucleic Acids 23:1403–1405

    Article  CAS  PubMed  Google Scholar 

  13. Woodson LC, Maus TP, Reiter C, Weinshilboum RM (1981) Rat thiopurine methyltransferase: regulation by testosterone. J Pharmacol Experim Ther 218:734–738

    Google Scholar 

  14. Kröplin T, Weyer N, Gutsche S, Iven H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265–271

    Google Scholar 

  15. Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651–662

    CAS  PubMed  Google Scholar 

  16. Bergan S, Rugstad HE, Klemetsdal B, Giverhaug T, Bentdal O, Sodal G, Hartmann A, Aarbakke J, Stokke O (1997) Possibilities for therapeutic drug monitoring or azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells. Ther Drug Monit 19:318–326

    Article  CAS  PubMed  Google Scholar 

  17. Van Meyel JJM, Gerlag PGG, Smits P, Russel FGM, Tan Y, Van Ginneken CAM, Gribnau FWJ (1992) Absorption of high dose furosemide (frusemide) in congestive heart failure. Clin Pharmacokinet 22:308–318

    CAS  PubMed  Google Scholar 

  18. Ponto LLB, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (part I). Clin Pharmacokinet 18:381–408

    CAS  PubMed  Google Scholar 

  19. Ruf G, Gera S, Luus HG, Trenk D, de la Rey N, Loffler K, Schulz W, Jähnchen E (1994) Pharmacokinetics and pharmacodynamics of ramipril and piretanide administrated alone and in combination. Eur J Clin Pharmacol 46:545–550

    Google Scholar 

  20. Berg KJ, Walstad RA, Bergh K (1983) The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Br J Clin Pharmacol 15:347–353

    CAS  PubMed  Google Scholar 

  21. Beermann B, Grind M (1987) Clinical pharmacokinetics of some newer diuretics. Clin Pharmacokinet 13:254–266

    CAS  PubMed  Google Scholar 

  22. Chocair PR, Duley JA, Simmonds HA, Cameron JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53:1051–1056

    CAS  PubMed  Google Scholar 

  23. Lin SN, Jessup K, Floyd M, Wang TP, van Buren CT, Caprioli RM, Kahan BD (1980) Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients. Transplantation 29:290–294

    CAS  PubMed  Google Scholar 

  24. McEvoy GK (ed) (2005) Azathioprine. AHFS drug information. American Society of Health System Pharmacists Inc, Bethesda, MD, pp 3654–3656

    Google Scholar 

  25. Elion GB, Bieber S, Hitchings GH (1954) The fate of 6-mercaptopurine in mice. Ann NY Acad Sci 60:297–303

    CAS  PubMed  Google Scholar 

  26. Venkataramanan R, Habucky K, Burckart GJ, Ptachcinski RJ (1989) Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet 16:134–161

    CAS  PubMed  Google Scholar 

  27. Vermeulen A (1976) Plasma levels and secretion rate of steroids with anabolic activity in man. Environ Qual Saf Suppl:171–180

    Google Scholar 

  28. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525–533

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by the Robert Bosch Foundation, Stuttgart, Germany. The technical assistance of Mrs. M. Schick and the secretarial help of Mrs. H. Bonilla Torres are highly appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich Klotz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xin, HW., Fischer, C., Schwab, M. et al. Thiopurine S-methyltransferase as a target for drug interactions. Eur J Clin Pharmacol 61, 395–398 (2005). https://doi.org/10.1007/s00228-005-0950-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0950-5

Keywords

Navigation